Katalog der Deutschen Nationalbibliothek

Go to:

Catalogue (Beta)

Knowledge Web

Person
Person

Person

Anita Pathil-Warth (1981-)

Ärztin

Name

Anita Pathil-Warth

Time

1981- (Date of birth and death)

Place

Heidelberg (Wirkungsort)
Deutschland

Gender

weiblich

Academic degree

PD Dr. med.

Profession

Ärztin (characteristic profession)

Variant

Anita Pathil- Warth
Anita Pathil (früherer Name)

Related

Klinikum Heidelberg

Further information

Diss. Medizinische Fakultät an der Universität Tübingen; Oberärztin, Medizinische Klinik, Abt. IV, Gastroenterologie und Hepatologie, Universitätsklinikum Heidelberg

Record type

Person

GND-Identifier

132644304

Record ID

132644304

Involved in

show all

A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B

HER2 gene (ERBB2) amplification is a low-frequency driver with potential predictive value in gallbladder carcinoma

HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis

Low frequency of mismatch repair deficiency in gallbladder cancer

Prognostic Impact of Carboxylesterase 2 in Cholangiocarcinoma

Programmed cell death ligand 1 (PD-L1, CD274) in cholangiocarcinoma – correlation with clinicopathological data and comparison of antibodies

Evolution of HCV patient characteristics and DAA regimens in the German Hepatitis C Registry (DHC-R) in 2014 and 2015

Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma

Could inherited predisposition drive non-obese fatty liver disease? Results from German tertiary referral centers

Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantation

Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantation

Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantation

Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study

Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center “real-life” cohort

Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center “real-life” cohort

Loss of aquaporin-4 expression and putative function in non-small cell lung cancer

Epigenetische Modulation durch Histondeacetylase-Inhibition als innovatives Therapieprinzip beim hepatozellulären Karzinom

Epigenetische Modulation durch Histondeacetylase-Inhibition als innovatives Therapieprinzip beim Hepatozellulären Karzinom
Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

DNB portal